<html>

<head>
    <meta name="viewport" content="width=1024, height=768, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="format-detection" content="telephone=no">
    <meta name="apple-mobile-web-app-capable" content="yes">
    <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">

    <title>iCVA Navigator</title>
    <!-- Global CSS -->
    <link href="shared/css/reset.css" type="text/css" rel="stylesheet" media="all" />
    <link href="shared/css/fonts.css" type="text/css" rel="stylesheet" media="all" />
    <link href="shared/css/global_traning.css" type="text/css" rel="stylesheet" media="all" />
    <!-- Page level CSS -->
    <link href="./css/style.css" type="text/css" rel="stylesheet" />

    <!-- Global JS -->
    <script type="text/javascript" src="shared/js/jquery.3.4.1.min.js"></script>

    <!-- Veeva JS -->
    <script type="text/javascript" src="shared/js/veeva_js/veeva-library.js"></script>
    <script type="text/javascript" src="shared/js/veeva_js/veeva_tranning.js"></script>

    <script type="text/javascript" src="shared/js/custom_svg_icons.js"></script>
    <script type="text/javascript" src="shared/js/global_traning.js"></script>
    <!-- <script type="text/javascript" src="shared/js/globalswipe.js"></script> -->
    <!-- <script type="text/javascript" src="shared/js/html5.js"></script> -->
    <script type="text/javascript" src="shared/js/iscroll.js"></script>
    <script type="text/javascript" src="shared/js/jqswipe.js"></script>
</head>

<body>
    <div id="ipad_div_menu">
        <div class="sonar-wrappernative">
            <div class="sonar-emitter">
                <div class="sonar-wave"></div>
                <div class="sonar-wave1"></div>
            </div>
        </div>
        <img src="./media/images/VeevaMenu.png" class="ipad_image_menu">
        <div id="ipad_button_menu" class="ipad_native_button"></div>
        <div id="ipad_button_marker" class="ipad_native_button"></div>
        <div id="ipad_button_back" class="ipad_native_button"></div>
        <div id="ipad_button_blue" class="ipad_native_button"></div>
        <div id="ipad_button_white" class="ipad_native_button"></div>
        <div id="ipad_button_red" class="ipad_native_button"></div>
    </div>
    <div class="container">
        <div id="touchCursor" style="display: none;"></div>
<div class="page_content" slideId="33">
            <video class="speaker_img_s33" playinline>
                <source src="./media/video/VO_33.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <img src="./media/images/txt/txt-33.png" class="message_img_s33">
            <img src="./media/images/nextBtn.png" class="button_img_s33 btn" data-km="" data-trng="34">
        </div>
        <div class="page_content" slideId="34">
            <video class="speaker_img_s34" playinline>
                <source src="./media/video/VO_34.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <img src="./media/images/txt/txt-34.png" class="message_img_s34">
            <img src="./media/images/nextBtn.png" class="button_img_s34 btn" data-km="" data-trng="35">
        </div>
        <div class="page_content" slideId="35">
            <!-- <img src="./media/images/speakerRight-1.png" class="speaker_img_s35"> -->
            <video class="speaker_img_s35" playinline>
                <source src="./media/video/VO_35.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">
                This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.
            </p>
            <img src="./media/images/txt/txt-35.png" class="message_img_s35">
            <img src="./media/images/note/note1-35.png" class="note1_img_s35">
            <img src="./media/images/note/note2-35.png" class="note2_img_s35">
            <img src="./media/images/nextBtn.png" class="button_img_s35 btn" data-km="" data-trng="36">
            <div class="sonar-wrapper2">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <img src="./media/images/3dotMenuVeeva.png" class="ThreeDotsMenu_img_s35 btn" data-trng="36">
        </div>
        <div class="page_content" slideId="36">
            <!-- <img src="./media/images/speakerleft-1.png" class="speaker_img_s36"> -->
            <video class="speaker_img_s36" playinline>
                <source src="./media/video/VO_36.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <img src="./media/images/txt/txt-36.png" class="message_img_s36">
            <!-- <img src="./media/images/speaker-round.png" class="speaker_round_img_s36"> -->
            <img src="./media/images/nextBtn.png" class="button_img_s36 btn" data-km="" data-trng="37">
            <img src="shared/media/images/guide_switch_on.png" class="GuideSwitch_img">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
        </div>
        <div class="page_content" slideId="37">
            <!-- <img src="./media/images/speakerRight-1.png" class="speaker_img_s37"> -->
            <video class="speaker_img_s37" playinline>
                <source src="./media/video/VO_37.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <img src="./media/images/txt/txt-37.png" class="message_img_s37">
            <!-- <img src="./media/images/speaker-round.png" class="speaker_round_img"> -->
            <!-- <img src="./media/images/nextBtn.png" class="button_img"> -->
            <img src="shared/media/images/guide_switch_on.png" class="GuideSwitch_img">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="menu_button_img_s37 btn" data-km="" data-trng="38"></div>
        </div>
        <div class="page_content" slideId="38">
            <!-- <img src="./media/images/speakerleft-1.png" class="speaker_img_s38"> -->
            <video class="speaker_img_s38" playinline>
                <source src="./media/video/VO_38.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <img src="./media/images/txt/txt-38.png" class="message_img_s38">
            <img src="shared/media/images/guide_switch_on.png" class="GuideSwitch_img">
            <img src="./media/images/note/notes1-38.png" class="note1_img_s38">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="menu_button_img_s38 btn" data-km="" data-trng="39"></div>
        </div>
        <div class="page_content" slideId="39">
            <!-- <img src="./media/images/speakerleft-1.png" class="speaker_img_s39"> -->
            <video class="speaker_img_s39" playinline>
                <source src="./media/video/VO_39.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <img src="./media/images/txt/txt-39.png" class="message_img_s39">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="menu_button_img_s39 btn" data-km="" data-trng="40"></div>
            <!-- <div class="btn_menu_home btn menu_btn" data-km="" data-trng="40"></div> -->
        </div>
        <div class="page_content" slideId="40">
            <!-- <img src="./media/images/speakerleft-1.png" class="speaker_img_s40"> -->
            <video class="speaker_img_s40" playinline>
                <source src="./media/video/VO_40.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <img src="./media/images/txt/txt-40.png" class="message_img_s40">
            <img src="shared/media/images/guide_switch_on.png" class="GuideSwitch_img">
            <!-- <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1 sonar-wave11"></div>
                </div>
            </div> -->
            <!-- <div class="overview_button_img_s40 btn" data-km="" data-trng="41"></div>
            <div class="patientType_button_img_s40 btn" data-km="" data-trng="41"></div>
            <div class="PSMA_button_img_s40 btn" data-km="" data-trng="41"></div>
            <div class="vision_button_img_s40 btn" data-km="" data-trng="41"></div>
            <div class="plan_button_img_s40 btn" data-km="" data-trng="41"></div>
            <div class="design_button_img_s40 btn" data-km="" data-trng="41"></div>
            <div class="summary_button_img_s40 btn" data-km="" data-trng="41"></div> -->
            <div class="highlight btn" data-km="" data-trng="41"></div>
        </div>
        <div class="page_content" slideId="41">
            <!-- <img src="./media/images/speakerleft-1.png" class="speaker_img_s41"> -->
            <video class="speaker_img_s41" playinline>
                <source src="./media/video/VO_41.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <img src="./media/images/txt/txt-41.png" class="message_img_s41">
            <img src="shared/media/images/guide_switch_on.png" class="GuideSwitch_img">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="button_img_s41 btn" data-km="" data-trng="42"></div>
        </div>
        <div class="page_content" slideId="42">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <div id="isi_popu_s42" class="popup" style="left: 0px; opacity: 1; display: block;">
                <div id="isi_overlay" class="popup_overlay"></div>
                <div id="isi_bg" class="popup_bg_s42">
                    <!-- <div class="popup_header">IMPORTANT SAFETY INFORMATION</div> -->
                    <div class="sonar-wrapper1">
                        <div class="sonar-emitter">
                            <div class="sonar-wave"></div>
                            <div class="sonar-wave1"></div>
                        </div>
                    </div>
                    <div class="sonar-wrapper2">
                        <div class="sonar-emitter">
                            <div class="sonar-wave"></div>
                            <div class="sonar-wave1"></div>
                        </div>
                    </div>
                    <div id="isi_content_wrapper" class="popup_content_wrapper popup_scroll_props">
                        <div id="isi_content" class="popup_scroll_content">
                            <div class="indication_wrapper">
                                <p class="isi_header">Indication</p>
                                <section class="indi_section_1">
                                    <p class="isi_text">PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) is indicated
                                        for the treatment of adult patients with prostate-specific membrane antigen
                                        <nobr>(PSMA)-positive</nobr> metastatic castration-resistant prostate cancer
                                        (mCRPC) who have been treated with androgen receptor pathway inhibition (ARPI)
                                        therapy, and
                                    </p>
                                    <ul class="isi_list">
                                        <li>are considered appropriate to delay taxane-based chemotherapy, or</li>
                                        <li>have received prior taxane-based chemotherapy</li>
                                    </ul>
                                </section>
                            </div>
                            <div class="isi_wrapper">
                                <p class="isi_header">IMPORTANT SAFETY INFORMATION</p>
                                <section class="isi_section_1">
                                    <p class="isi_sub_header">Risk From Radiation Exposure</p>
                                    <p class="isi_text">PLUVICTO contributes to a patient’s long-term cumulative
                                        radiation exposure, which is associated with an increased risk for cancer.</p>
                                    <p class="isi_text">Minimize radiation exposure to patients, medical personnel, and
                                        others during and after treatment with PLUVICTO consistent with institutional
                                        practices, patient treatment procedures, Nuclear Regulatory Commission
                                        patient-release guidance, and instructions to the patient for follow-up
                                        radiation protection.</p>
                                    <p class="isi_text">Ensure patients increase oral fluid intake and advise them to
                                        void as often as possible to reduce bladder radiation.</p>
                                    <p class="isi_text">To minimize radiation exposure to others, advise patients to
                                        limit close contact (less than <nobr>3 feet)</nobr> with household contacts for
                                        2 days or with children and pregnant women for <nobr>7 days</nobr>, to refrain
                                        from sexual activity for 7 days, and to sleep in a separate bedroom from
                                        household contacts for 3 days, from children for 7 days, or from pregnant women
                                        for <nobr>15 days.</nobr>
                                    </p>

                                </section>

                                <section class="isi_section_2">
                                    <p class="isi_sub_header">Myelosuppression</p>
                                    <p class="isi_text">PLUVICTO can cause severe and life-threatening myelosuppression.
                                        In the PSMAfore study, grade 3 or 4 decreased hemoglobin (7%), decreased
                                        leukocytes (4.4%), decreased neutrophils (3.5%), and decreased platelets (2.7%)
                                        occurred in patients treated with PLUVICTO. One death occurred due to bone
                                        marrow failure during long-term follow-up in a patient who received PLUVICTO. In
                                        the VISION study, 4 myelosuppression-related deaths occurred. </p>
                                    <p class="isi_text">Perform complete blood counts before and during treatment with
                                        PLUVICTO. Withhold, reduce dose, or permanently discontinue PLUVICTO based on
                                        severity of myelosuppression.</p>

                                </section>

                                <section class="isi_section_3">
                                    <p class="isi_sub_header">Renal Toxicity</p>
                                    <p class="isi_text">PLUVICTO can cause severe renal toxicity. In the PSMAfore study,
                                        grade 3 or 4 acute kidney injury (1.3%) occurred in patients treated with
                                        PLUVICTO.</p>
                                    <p class="isi_text">Advise patients to remain well hydrated and to urinate
                                        frequently before and after administration of PLUVICTO. Perform kidney function
                                        laboratory tests, including serum creatinine and calculated creatinine clearance
                                        (CrCl), before and during treatment. Withhold, reduce dose, or permanently
                                        discontinue PLUVICTO based on severity of renal toxicity.</p>

                                </section>

                                <section class="isi_section_4">
                                    <p class="isi_sub_header">Embryo-Fetal Toxicity</p>
                                    <p class="isi_text">The safety and efficacy of PLUVICTO have not been established in
                                        females. Based on its mechanism of action, PLUVICTO can cause fetal harm. No
                                        animal studies using lutetium Lu 177 vipivotide tetraxetan have been conducted
                                        to evaluate its effect on female reproduction and embryo-fetal development;
                                        however, radioactive emissions, including those from PLUVICTO, can cause fetal
                                        harm. Advise males with female partners of reproductive potential to use
                                        effective contraception during treatment with PLUVICTO and for 14 weeks after
                                        the last dose.</p>


                                </section>

                                <section class="isi_section_4">
                                    <p class="isi_sub_header">Infertility</p>
                                    <p class="isi_text">The recommended cumulative dose of 44.4 GBq of PLUVICTO results
                                        in a <nobr>radiation-absorbed</nobr> dose to the testes within the range where
                                        PLUVICTO may cause temporary or permanent infertility.</p>


                                </section>

                                <section class="isi_section_4">
                                    <p class="isi_sub_header">Adverse Reactions and Laboratory Abnormalities</p>
                                    <p class="isi_text">In the pooled safety population for the PSMAfore and VISION
                                        studies (N=756), the most common (≥20%) adverse reactions, including laboratory
                                        abnormalities, were decreased lymphocytes (83%), decreased hemoglobin (65%),
                                        fatigue (49%), dry mouth (46%), decreased platelets (40%), decreased estimated
                                        glomerular filtration rate (37%), nausea (35%), decreased neutrophils (31%),
                                        decreased calcium (29%), decreased sodium (27%), increased aspartate
                                        aminotransferase (26%), increased alkaline phosphatase (24%), arthralgia (22%),
                                        decreased appetite (21%), increased potassium (21%), constipation (21%), and
                                        back pain (21%).</p>

                                    <p><b>
                                            Please see full <a
                                                href="https://www.novartis.com/us-en/sites/novartis_us/files/pluvicto.pdf">Prescribing
                                                Information</a>.</b>

                                    </p>
                                    <div>
                                        <img id="novartisLogo" src="shared/media/images/Novartis_logo_VM_page.png"
                                            alt="">
                                        <p></p>


                                        <img id="pluvicto_logo" src="shared/media/images/brand_logo1.png" alt="">

                                    </div>

                                    <p class="isi_text_section"><span class="fi_rst"><b>Novartis Pharmaceuticals
                                                Corporation</b><br>East Hanover, New Jersey 07936-1080</span> <span
                                            class="isi_year">©2025 Novartis</span><span
                                            class="isi_date">6/25</span><span class="isi_contentid">FA-11383644</span>
                                    </p>

                                </section>
                            </div>
                        </div>
                    </div>
                    <div id="isi_close" class="popup_close  btn" data-km="" data-trng="45">
                        <svg viewBox="0 0 24 24" class="icon_svg popup_close_svg">
                            <use href="#svg_icons_menu_close"></use>
                        </svg>
                    </div>
                </div>
            </div>
            <!-- <img src="./media/images/speaker-round.png" class="speaker_round_img"> -->
            <!-- <img src="./media/images/nextBtn.png" class="button_img"> -->
            <!-- <img src="./media/images/GuideSwitch.png" class="GuideSwitch_img"> -->
            <!-- <img src="./media/images/speakerLeft-1.png" class="speaker_img_s42"> -->
            <video class="speaker_img_s42" playinline>
                <source src="./media/video/VO_42.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-42.png" class="message_img_s42">
            <img src="./media/images/note/notes-42.png" class="note1_img_s42">

            <img src="./media/images/txt/txt-44.png" class="message_img_1_s42">
            <!-- <img src="./media/images/speakerRight-1.png" class="speaker_img_1_s42"> -->

            <video class="speaker_img_s44" playinline>
                <source src="./media/video/VO_44.mp4" type="video/mp4">
            </video>
            <!-- <div class="scroll_button_img button_img" data-km="" data-trng="43"></div> -->
            <div class="cancle_button_img_s42 btn" data-km="" data-trng="45"></div>
        </div>

        <div class="page_content" slideId="43"></div>
        <div class="page_content" slideId="44"></div>

        <div class="page_content" slideId="45">
            <!-- <img src="./media/images/speakerleft-1.png" class="speaker_img_s45"> -->
            <video class="speaker_img_s45" playinline>
                <source src="./media/video/VO_45.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <img src="./media/images/txt/txt-45.png" class="message_img_s45">
            <!-- <img src="./media/images/speaker-round.png" class="speaker_round_img"> -->
            <!-- <img src="./media/images/nextBtn.png" class="button_img"> -->
            <img src="shared/media/images/guide_switch_on.png" class="GuideSwitch_img">
            <img src="./media/images/note/notes-45.png" class="note1_img_s45">
            <div class="sonar-wrapper45">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="button_img_s45" data-km=""></div>
        </div>
        <div class="page_content" slideId="46">
            <div class="sonar-wrapper2">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="button_close_s46 btn" data-km="" data-trng="47"></div>
            <!-- <img src="./media/images/speakerleft-1.png" class="speaker_img_s46"> -->
            <video class="speaker_img_s46" playinline>
                <source src="./media/video/VO_46.mp4" type="video/mp4">
            </video>
            <!-- <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p> -->
            <img src="./media/images/txt/txt-46.png" class="message_img_s46">
        </div>
        <div class="page_content" slideId="47">
            <!-- <img src="./media/images/speakerleft-1.png" class="speaker_img_s47"> -->
            <video class="speaker_img_s47" playinline>
                <source src="./media/video/VO_47.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <img src="./media/images/txt/txt-47.png" class="message_img_s47">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="button_img_s47 btn" data-km="" data-trng="48"></div>
        </div>
        <div class="page_content" slideId="48">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <div id="ref_popup" class="popup" style="left: 0px; opacity: 1; display: block;">
                <div id="ref_overlay" class="popup_overlay"></div>
                <div id="ref_bg" class="popup_bg">
                    <div class="sonar-wrapper1">
                        <div class="sonar-emitter">
                            <div class="sonar-wave"></div>
                            <div class="sonar-wave1"></div>
                        </div>
                    </div>
                    <p class="popup_header">References:</p>
                    <div id="ref_content_wrapper" class="popup_content_wrapper popup_scroll_props"
                        style="touch-action: none;">
                        <div id="ref_content" class="popup_scroll_content"
                            style="transform: translate(0px, 0px) translateZ(0px);">
                            <ol>
                                <li>Pluvicto. Prescribing information. Novartis Pharmaceuticals Corp.</li>
                                <li>Morris MJ, Castellano D, Herrmann K, et al; PSMAfore Investigators.
                                    <sup>177</sup>Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor
                                    therapy for taxane-naive patients with progressive metastatic castration-resistant
                                    prostate cancer (PSMAfore): a phase 3, randomised, controlled trial. <i>Lancet.</i>
                                    2024;404(10459):1227-1239. <nobr>doi:10.1016/S0140-6736(24)01653-2</nobr>
                                </li>
                                <li>Shore ND, Laliberté F, Ionescu-Ittu R, et al. Real-world treatment patterns and
                                    overall survival of patients with metastatic castration-resistant prostate cancer in
                                    the US prior to PARP inhibitors. <i>Adv Ther.</i> 2021;38(8):4520-4540. <nobr>
                                        doi:10.1007/s12325-021-01823-6</nobr>
                                </li>
                                <li>Freedland SJ, Davis M, Epstein AJ, Arondekar B, Ivanova JI. Real-world treatment
                                    patterns and overall survival among men with metastatic castration-resistant
                                    prostate cancer (mCRPC) in the US Medicare population. <i>Prostate Cancer Prostatic
                                        Dis.</i> 2024;27(2):327-333. doi:10.1038/s41391-023-00725-8</li>
                                <li>Kuppen MCP, Westgeest HM, van den Eertwegh AJM, et al. Health-related quality of
                                    life and pain in a real-world <nobr>castration-resistant</nobr> prostate cancer
                                    population: results from the PRO-CAPRI Study in the Netherlands. <i>Clin Genitourin
                                        Cancer.</i> 2020;18(3):e233-e253. doi:10.1016/j.clgc.2019.11.015</li>
                                <li>Hupe MC, Philippi C, Roth D, et al. Expression of prostate-specific membrane antigen
                                    (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at
                                    time of initial diagnosis. <i>Front Oncol.</i> 2018;8:623.
                                    doi:10.3389/fonc.2018.00623</li>
                                <li>Pomykala KL, Czernin J, Grogan TR, Armstrong WR, Williams J, Calais J. Total-body
                                    <sup>68</sup>Ga-PSMA-11 PET/CT for bone metastasis detection in prostate cancer
                                    patients: potential impact on bone scan guidelines. <i>J Nucl Med.</i>
                                    2020;61(3):405-411. <nobr>doi:10.2967/jnumed.119.230318</nobr>
                                </li>
                                <li>Sartor O, de Bono J, Chi KN, et al; VISION Investigators. Lutetium-177–PSMA-617 for
                                    metastatic castration-resistant prostate cancer. <i>N Engl J Med.</i>
                                    2021;385(12):1091-1103. doi:10.1056/NEJMoa2107322</li>
                                <li>Data on file. PLUVICTO NPS Numbers. Novartis Pharmaceuticals Corp; 2025.</li>
                                <li>Morris MJ, Castellano D, Herrmann K, et al; PSMAfore Investigators.
                                    <sup>177</sup>Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor
                                    therapy for taxane-naive patients with progressive metastatic castration-resistant
                                    prostate <nobr>cancer (PSMAfore): a phase 3,</nobr> randomised, controlled trial.
                                    <i>Lancet.</i> 2024;404(10459)(suppl 1):1227-1239. <nobr>
                                        doi:10.1016/S0140-6736(24)01653-2</nobr>
                                </li>
                                <li>Data on file. Overall Survival–Final Analysis. Novartis Pharmaceuticals Corp; 2025.
                                </li>
                                <li>Morris MJ, Castellano D, Herrmann K, et al; PSMAfore Investigators.
                                    <sup>177</sup>Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor
                                    therapy for taxane-naive patients with progressive metastatic castration-resistant
                                    prostate <nobr>cancer (PSMAfore): a phase 3,</nobr> randomised, controlled trial.
                                    <i>Lancet.</i> 2024;404(10459)(suppl 3):1227-1239. <nobr>
                                        doi:10.1016/S0140-6736(24)01653-2</nobr>
                                </li>
                                <li>Morris MJ, Castellano D, Herrmann K, et al; PSMAfore Investigators.
                                    <sup>177</sup>Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor
                                    therapy for taxane-naive patients with progressive metastatic castration-resistant
                                    prostate <nobr>cancer (PSMAfore): a phase 3,</nobr> randomised, controlled trial.
                                    <i>Lancet.</i> 2024;404(10459)(suppl 2):1227-1239. <nobr>
                                        doi:10.1016/S0140-6736(24)01653-2</nobr>
                                </li>
                                <li>Sartor O, de Bono J, Chi KN, et al; VISION Investigators. Lutetium-177–PSMA-617 for
                                    metastatic castration-resistant prostate cancer. <i>N Engl J Med.</i>
                                    2021;385(12)(suppl):1091-1103. doi:10.1056/NEJMoa2107322 </li>
                                <li>Data on file. VISION [PSMA-617-01] study. Novartis Pharmaceuticals Corp; 2024.</li>
                                <li>Sartor O, de Bono J, Chi KN, et al; VISION Investigators. Lutetium-177–PSMA-617 for
                                    metastatic castration-resistant prostate cancer. <i>N Engl J Med.</i>
                                    2021;385(12)(protocol):1091-1103. doi:10.1056/NEJMoa2107322</li>
                                <li>Data on file. Order Lead Time. Novartis Pharmaceuticals Corp; 2025.</li>
                                <li>Data on file. Novartis Technical Operations. Novartis Pharmaceuticals Corp; 2024.
                                </li>
                                <li>Data on file. MMIT Market Access Claims. March 2025.</li>
                                <li>Data on file. PLUVICTO IQVIA LAAD data analysis. Novartis Pharmaceuticals Corp; Jan
                                    2023 to Jun 2024.</li>
                                <li>Liu H, Rajasekaran AK, Moy P, et al. Constitutive and antibody-induced
                                    internalization of prostate-specific membrane antigen. <i>Cancer Res.</i>
                                    1998;58(18):4055-4060.</li>
                                <li>Ruigrok EAM, van Vliet N, Dalm SU, et al. Extensive preclinical evaluation of
                                    lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy.
                                    <i>Eur J Nucl Med Mol Imaging.</i> 2021;48(5):1339-1350.
                                    doi:10.1007/s00259-020-05057-6
                                </li>
                                <li>Rajasekaran SA, Anilkumar G, Oshima E, et al. A novel cytoplasmic tail MXXXL motif
                                    mediates the internalization of <nobr>prostate-specific</nobr> membrane antigen.
                                    <i>Mol Biol Cell.</i> 2003;14(12):4835-4845. doi:10.1091/mbc.e02-11-0731
                                </li>
                                <li>Nonnekens J, van Kranenburg M, Beerens CEMT, et al. Potentiation of peptide receptor
                                    radionuclide therapy by the PARP inhibitor olaparib. <i>Theranostics</i>.
                                    2016;6(11):1821-1832. doi:10.7150/thno.15311</li>
                                <li>Fendler WP, Stuparu AD, Evans-Axelsson S, et al. Establishing
                                    <sup>177</sup>Lu-PSMA-617 radioligand therapy in a syngeneic model of murine
                                    prostate cancer. <i>J Nucl Med.</i> 2017;58(11):1786-1792.
                                    doi:10.2967/jnumed.117.193359
                                </li>
                            </ol>
                        </div>
                        <div class="iScrollVerticalScrollbar iScrollLoneScrollbar"
                            style="position: absolute; z-index: 9999; width: 7px; bottom: 2px; top: 2px; right: 1px; overflow: hidden;">
                            <div class="iScrollIndicator"
                                style="box-sizing: border-box; position: absolute; border: 1px solid rgba(255, 255, 255, 0.9); border-radius: 3px; width: 100%; transition-duration: 0ms; display: block; height: 270px; transform: translate(0px, 0px) translateZ(0px);">
                            </div>
                        </div>
                    </div>
                    <div id="ref_close" class="popup_close btn" data-km="" data-trng="50">
                        <svg viewBox="0 0 24 24" class="icon_svg popup_close_svg">
                            <use href="#svg_icons_menu_close"></use>
                        </svg>
                    </div>
                </div>
            </div>
            <!-- <img src="./media/images/speakerRight-1.png" class="speaker_img_s48"> -->
            <video class="speaker_img_s48" playinline>
                <source src="./media/video/VO_48.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-48.png" class="message_img_s48">
            <!-- <div class="scroll_button_img_s48 btn" data-km="" data-trng="49"></div> -->
            <div class="cancle_button_img_s48 btn" data-km="" data-trng="50"></div>
        </div>
        <div class="page_content" slideId="49"></div>
        <div class="page_content" slideId="50">
            <!-- <img src="./media/images/speakerleft-1.png" class="speaker_img_50"> -->
            <video class="speaker_img_s50" playinline>
                <source src="./media/video/VO_50.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <img src="./media/images/txt/txt-50.png" class="message_img_s50">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="button_img_s50 btn" data-km="" data-trng="51"></div>
        </div>
        <div class="page_content" slideId="51">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <div id="footnotes_popup" class="popup" style="left: 0px; opacity: 1; display: block;">
                <div id="footnotes_overlay" class="popup_overlay"></div>
                <div id="footnotes_bg" class="popup_bg_s51 video_popup_bg popup_bg_small_v2">
                    <p class="popup_header">Resources</p>
                    <div id="footnotes_content_wrapper" class="popup_content_wrapper">
                        <div id="footnotes_content" class="popup_scroll_content">
                            <div id="videos_header" class="resources_header">
                                <svg viewBox="0 0 24 24" class="icon_svg" id="video_icon_svg">
                                    <use href="#svg_icons_ondemand_video"></use>
                                </svg>
                                <p class="resources_section_header">Videos</p>
                            </div>
                            <div class="videos_wrapper">
                                <!-- Added via JS file -->
                                <div class="video_resource">
                                    <div class="video_thumbnail preview_btn" data-type="video"
                                        data-target="video_sample.mp4" pop-modal="pop51">
                                        <div class="img-popup"></div>
                                        <svg viewBox="0 0 24 24" class="icon_svg video_play_icon">
                                            <use href="#svg_icons_play_arrow"></use>
                                        </svg>
                                    </div>
                                    <div>MOA</div>
                                    <div class="nvs_checkbox_item" data-frag="7204">
                                        <div class="nvs_checkbox_icon "></div>
                                    </div>
                                </div>
                            </div>
                            <div id="docs_header" class="resources_header">
                                <svg viewBox="0 0 24 24" class="icon_svg" id="doc_icon_svg">
                                    <use href="#svg_icons_text_snippet"></use>
                                </svg>
                                <p class="resources_section_header">Documents</p>
                            </div>
                            <div class="docs_wrapper">
                                <!-- Added via JS file -->
                                <div class="doc_resource">
                                    <div class="resource_detail">
                                        <p class="nvs_link preview_btn" data-type="pdf"
                                            data-target="FA-11348514 PLUVICTO mCRPC Monitoring Brochure Label Update.pdf">
                                            <span class="nvs_link_text">Monitoring Brochure</span>
                                            <svg width="24" height="24" viewBox="0 0 24 24" class="icon_svg">
                                                <use href="#svg_icons_launch"></use>
                                            </svg>
                                        </p>
                                        <div class="nvs_checkbox_item" data-frag="7204">
                                            <div class="nvs_checkbox_icon "></div>
                                        </div>
                                    </div>
                                </div>
                                <div class="doc_resource">
                                    <div class="resource_detail">
                                        <p class="nvs_link" data-type="pdf"
                                            data-target="FA-11379639 PSMAfore Patient Profiles Slim Jim.pdf">
                                            <span class="nvs_link_text">Experience Brochure</span>
                                            <svg width="24" height="24" viewBox="0 0 24 24" class="icon_svg">
                                                <use href="#svg_icons_launch"></use>
                                            </svg>
                                        </p>
                                        <div class="nvs_checkbox_item" data-frag="7204">
                                            <div class="nvs_checkbox_icon "></div>
                                        </div>
                                    </div>
                                </div>
                                <div class="doc_resource">
                                    <div class="resource_detail">
                                        <p class="nvs_link preview_btn" data-type="pdf"
                                            data-target="FA-11349998 PLUVICTO Administration Guide.pdf">
                                            <span class="nvs_link_text">Treatment Guide</span>
                                            <svg width="24" height="24" viewBox="0 0 24 24" class="icon_svg">
                                                <use href="#svg_icons_launch" target="_blank"></use>
                                            </svg>
                                        </p>
                                        <div class="nvs_checkbox_item" data-frag="7203">
                                            <div class="nvs_checkbox_icon "></div>
                                        </div>
                                    </div>
                                </div>
                                <div class="doc_resource">
                                    <div class="resource_detail">
                                        <p class="nvs_link preview_btn" data-type="pdf"
                                            data-target="pluvicto-comprehensive-brochure.pdf">
                                            <span class="nvs_link_text">Comprehensive Patient Brochure</span>
                                            <svg width="24" height="24" viewBox="0 0 24 24" class="icon_svg">
                                                <use href="#svg_icons_launch" target="_blank"></use>
                                            </svg>
                                        </p>
                                        <div class="nvs_checkbox_item" data-frag="7203">
                                            <div class="nvs_checkbox_icon "></div>
                                        </div>
                                    </div>
                                </div>
                                <div class="doc_resource">
                                    <div class="resource_detail">
                                        <p class="nvs_link preview_btn" data-type="pdf"
                                            data-target="FA-11379639 PSMAfore Patient Profiles Slim Jim.pdf">
                                            <span class="nvs_link_text">Patient Profiles Brochure</span>
                                            <svg width="24" height="24" viewBox="0 0 24 24" class="icon_svg">
                                                <use href="#svg_icons_launch" target="_blank"></use>
                                            </svg>
                                        </p>
                                        <div class="nvs_checkbox_item" data-frag="7203">
                                            <div class="nvs_checkbox_icon "></div>
                                        </div>
                                    </div>
                                </div>
                            </div>
                            <div id="email_btn_wrapper">
                                <div id="email_resources" class="nvs_btn nvs_btn_primary disabled">
                                    Email
                                    <svg viewBox="0 0 24 24" class="icon_svg nvs_white">
                                        <use href="#svg_icons_email"></use>
                                    </svg>
                                </div>
                                <div class="res_QR"></div>
                            </div>
                            <div class="banner-51">
                                <img src="./media/images/slide-51_banner.png" />
                            </div>
                            <div id="footnotes_close" class="popup_close  btn" data-km="" data-trng="52">
                                <svg viewBox="0 0 24 24" class="icon_svg popup_close_svg">
                                    <use href="#svg_icons_menu_close"></use>
                                </svg>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div id="video_popup_51" class="popup" style="left: 0px; opacity: 1; display: none;">
                <video id="resource_video" class="" controls="" style="">
                    <source id="video_src" src="shared/media/videos/video_sample.mp4" type="video/mp4">
                </video>
                <div id="video_close_51" class="popup_close popup_close_btn video_popup_close_btn">
                    <svg viewBox="0 0 24 24" class="icon_svg popup_close_svg">
                        <use href="#svg_icons_menu_close"></use>
                    </svg>
                </div>
            </div>
            <!-- <img src="./media/images/speakerRight-1.png" class="speaker_img_s51"> -->
            <video class="speaker_img_s51" playinline>
                <source src="./media/video/VO_51.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-51.png" class="message_img_s51">
            <img src="./media/images/note/notes-51.png" class="note1_img_s51">
        </div>
        <div id="page_content_52" class="page_content" slideId="52">
            <p class="txt_footer_1">
                This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.
            </p>
            <video class="speaker_img_s52" playinline>
                <source src="./media/video/VO_52.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-52.png" class="message_img_s52">
            <img src="shared/media/images/guide_switch_on.png" class="GuideSwitch_img">
            <img src="./media/images/note/notes-52.png" class="note1_img_s52">
            <img src="./media/images/nextBtn.png" class="button_img_s52 btn" data-km="" data-trng="53">
            <!-- <div class="button_img_s52 btn" data-km="" data-trng="53"></div> -->
        </div>
        <div class="page_content" slideId="53">
            <!-- <img src="./media/images/speakerRight-1.png" class="speaker_img_s53"> -->
            <video class="speaker_img_s53" playinline>
                <source src="./media/video/VO_53.mp4" type="video/mp4">
            </video>
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <img src="./media/images/txt/txt-53.png" class="message_img_s53">
            <!-- <img src="./media/images/speaker-round.png" class="speaker_round_img"> -->
            <!-- <img src="./media/images/nextBtn.png" class="button_img"> -->
            <img src="shared/media/images/guide_switch_on.png" class="GuideSwitch_img">
            <img src="./media/images/note/notes-53.png" class="note1_img_s53">
            <img src="./media/images/btn_positive.png" class="btn_positive_s53 ipad_button_s53">
            <img src="./media/images/btn_netural.png" class="btn_netural_s53 ipad_button_s53">
            <img src="./media/images/btn_negative.png" class="btn_negative_s53 ipad_button_s53">
            <!-- <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div> -->
            <img src="./media/images/nextBtn.png" class="button_img_s53 btn" data-km="" data-trng="54">
        </div>
    </div>
</body>
<script type="text/javascript" src="./js/script.js"></script>

</html>